非小细胞肺癌的影像组学生物标志物:18F-FDG PET/CT 对程序性死亡配体1状态的表征
这项回顾性研究纳入394例非小细胞肺癌患者,分为训练集275例和测试集119例,提取18F-FDG PET/CT影像组学特征并用五种机器学习分类器建模。基于PET结节内区域和逻辑回归分类器的模型表现最佳,测试集AUC为0.813(95%CI 0.812, 0.821)。最终由三个PET影像组学特征构成的影像组学标签可无创区分PD-L1阳性与阴性。
要点
- 基于PET结节内区域和逻辑回归分类器的影像组学模型在测试集表现最佳,AUC为0.813(95%CI 0.812, 0.821)。
- 加入临床特征未提高测试集AUC,为0.806(95%CI 0.801, 0.810)。
- 最终PD-L1状态影像组学标签由三个PET影像组学特征构成。
核心结论
- 本研究表明,基于18F-FDG PET/CT的影像组学标签可作为无创生物标志物,用于区分非小细胞肺癌患者PD-L1阳性与阴性。
研究设计与样本
- 回顾性研究纳入394例合格患者,按275例训练集和119例测试集划分;由放射科医师在轴位CT图像上手动分割感兴趣结节,采用空间位置匹配法匹配CT与PET图像位置并提取影像组学特征;使用五种不同机器学习分类器构建影像组学模型并评估性能。
诊断标准与关键数值
- 基于PET结节内区域和逻辑回归分类器的影像组学模型在测试集表现最佳,AUC为0.813(95%CI 0.812, 0.821);加入临床特征后测试集AUC为0.806(95%CI 0.801, 0.810);最终PD-L1状态影像组学标签由三个PET影像组学特征构成。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To present an integrated 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET)/computed tomography (CT) radiomic characterisation of programmed death-ligand 1 (PD-L1) status in non-small-cell lung cancer (NSCLC).
MATERIALS AND METHODS: In this retrospective study, 18F-FDG PET/CT images and clinical data of 394 eligible patients were divided into training (n=275) and test sets (n=119). Next, the corresponding nodule of interest was segmented manually on the axial CT images by radiologists. After which, the spatial position matching method was used to match the image positions of CT and PET, and radiomic features of the CT and PET images were extracted. Radiomic models were built using five different machine-learning classifiers and the performance of the radiomic models were further evaluated. Finally, a radiomic signature was established to predict the PD-L1 status in patients with NSCLC using the features in the best performing radiomic model.
RESULTS: The radiomic model based on the PET intranodular region determined using the logistic regression classifier preformed best, yielding an area under the receiver operating characteristics curve (AUC) of 0.813 (95% CI: 0.812, 0.821) on the test set. The clinical features did not improve the test set AUC (0.806, 95% CI: 0.801, 0.810). The final radiomic signature for PD-L1 status was consisted of three PET radiomic features.
CONCLUSION: This study showed that an 18F-FDG PET/CT-based radiomic signature could be used as a non-invasive biomarker to discriminate PD-L1-positive from PD-L1-negative in patients with NSCLC.
引用
- Wang, He, Song, et al. The radiomic biomarker in non-small cell lung cancer: 18F-FDG PET/CT characterisation of programmed death-ligand 1 status. Clin Radiol. 2023. PMID: 37419772. doi:10.1016/j.crad.2023.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。